« Not All Bruton’s Tyrosine Kinase Inhibitors Are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-Covalent BTK Inhibitors ». Actualité hématologique Au Canada, vol. 5, nᵒ s02, mai 2026, p. 2–7, https://doi.org/10.58931/cht.2026.5s0282.